BioPharma Credit (LON:BPCR) Hits New 12-Month High – Should You Buy?

BioPharma Credit (LON:BPCRGet Free Report) hit a new 52-week high on Wednesday . The stock traded as high as GBX 0.94 and last traded at GBX 0.93, with a volume of 2341629 shares traded. The stock had previously closed at GBX 0.92.

BioPharma Credit Price Performance

The company has a market cap of £10.55 million, a price-to-earnings ratio of 0.09 and a beta of 0.22. The firm’s fifty day moving average price is GBX 0.91 and its 200-day moving average price is GBX 0.90.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.